| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of R&D, Coo-novitium Ops
1 company
Shanmugam Muthusamy is a Head Of R&D, Coo-novitium Ops at ANI PHARMACEUTICALS INC. Recent SEC Form 4 filings include 2 buys and 16 sells.
Estimated insider holdings value: $35.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $61.81 | $3,090,616.61 | -1.5% | -14.1% | -0.0% | |
| Aug 29, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $63.22 | $3,160,750.00 | -2.1% | -19.6% | -1.3% | |
| Aug 15, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $61.35 | $3,067,449.50 | -2.1% | -16.5% | -4.3% | |
| Jul 21, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 23,469 | $52.02 | $1,220,844.12 | -0.6% | +9.8% | +19.2% | |
| Jul 18, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 26,531 | $51.02 | $1,353,598.86 | -0.7% | +12.9% | +21.4% | |
| Jun 22, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 40,000 | $51.75 | $2,070,011.86 | -39.6% | +17.4% | +13.6% | |
| Mar 17, 2022 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Buy | 10,000 | $27.65 | $276,503.00 | +74.3% | -16.1% | +38.9% |